(Q57302776)

title

Monitoring of long-term toxicities of HIV treatments (English)

0 references

Monitoring of long-term toxicities of HIV treatments: an international perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

29 March 2024

8

Stephen Evans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

15

Munir Pirmohamed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

author name string

Greg Bisson

1

0 references

Robert Gross

2

0 references

Veronica Miller

3

0 references

Ian Weller

4

0 references

Alexander Walker

5

0 references

Peter Arlett

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Andrew Carr

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

David Graham

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Amy Justice

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Carmen Kreft-Jais

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Jens D. Lundgren

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Bob Munk

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Jeff Murray

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

David Pizzuti

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Ana Szarfman

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

Writing group

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600511

29 March 2024

language of work or name

English

0 references

publication date

November 2003

0 references

21 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14600511

29 March 2024

0 references

17

0 references

issue

17

0 references

page(s)

2407-2417

0 references

cites work

Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial

1

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

29 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Trust and the acceptance of and adherence to antiretroviral therapy

29 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Attitudinal survey of voluntary reporting of adverse drug reactions

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

The medical dictionary for regulatory activities (MedDRA).

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

A model for the future conduct of pharmacovigilance

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Toward improved adverse event/suspected adverse drug reaction reporting

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy

29 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00002

29 March 2024

Identifiers

0 references